Tortoise Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-400
Closed -$20K 1590
2025
Q2
$20K Sell
400
-1,000
-71% -$777K ﹤0.01% 507
2025
Q1
$41K Buy
1,400
+800
+133% +$666K ﹤0.01% 401
2024
Q4
$21K Hold
600
﹤0.01% 535
2024
Q3
$17.7K Hold
600
﹤0.01% 568
2024
Q2
$18K Sell
600
-500
-45% -$400K ﹤0.01% 549
2024
Q1
$8.82K Buy
1,100
+600
+120% +$427K ﹤0.01% 642
2023
Q4
$13.3K Buy
+500
New +$292K ﹤0.01% 532

Other funds holding LLY

Tortoise Investment Management's LLY Position: Q2 2026 in Review

Tortoise Investment Management increased its Eli Lilly (LLY) stake by 6.7% in Q2 2026, buying an estimated $83.8K and bringing the position to 1,314 shares worth $1.58M. The position accounts for 0.12% of the portfolio, ranked #111.

Tortoise Investment Management first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.67M in Q3 2024. 4,639 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Tortoise Investment Management held 1,314 shares of Eli Lilly worth $1.58M as of Q2 2026.
  • Tortoise Investment Management bought 82 Eli Lilly shares in Q2 2026, an estimated $83.8K.
  • Eli Lilly made up 0.12% of Tortoise Investment Management's portfolio in Q2 2026, its #111 holding.
  • Tortoise Investment Management first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • Tortoise Investment Management's Eli Lilly position peaked at $1.67M in Q3 2024.
  • 4,639 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Tortoise Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.